FindTrial
Sign In

Evaluation of Benztropine for Cocaine Craving - 2

Evaluation of Efficacy of Benztropine for Cocaine Craving

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00000333
Enrollment
0
Registered
1999-09-21
Start date
2001-05-31
Completion date
2003-04-30
Last updated
2017-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cocaine-Related Disorders

Brief summary

The purpose of this study is to compare the efficacy of benztropine (or DA reuptake inhibitor) with atropine and placebo in affecting stimulated craving to cocaine cues.

Interventions

DRUGBenztropine

Sponsors

Washington D.C. Veterans Affairs Medical Center
CollaboratorFED
National Institute on Drug Abuse (NIDA)
Lead SponsorNIH

Study design

Primary purpose
TREATMENT

Eligibility

Sex/Gender
ALL
Age
22 Years to 48 Years
Healthy volunteers
No

Inclusion criteria

Please contact site for information.

Design outcomes

Primary

MeasureTime frame
Stimulated and non-stimulated craving—

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026